简介
浙江震元生物科技有限公司系深交所上市的浙江震元股份有限公司（SZ：000705）旗下的控股子公司，由浙江震元股份有限公司和其全资子公司浙江震元制药有限公司共同出资的国有新办企业。公司注册资本3亿元，位于浙江省绍兴市杭州湾上虞经济技术开发区，距离杭州市80多公里，上海市170多公里。
公司坚持“科技是第一生产力”的思想，遵循 “绿色高端、世界领先”、“积极抢占全球行业制高点，全面重塑产业核心竞争力”的高质量发展理念，瞄准“健康中国”建设大方向 ，紧抓全球合成生物技术应用兴起机遇，依托中国科学院、国内著名大学等研究机构的科研合作，采用基于合成生物技术的生物发酵法生产质量优秀、环境友好的生命营养品。
公司生产经营的产品包括氨基酸、抗氧化剂、健康糖类、功能性脂肪酸等，主要用于医药、食品、保健品、饲料等领域。
公司秉持“以绿色制造不断满足人民健康生活需求”的使命，致力于将企业打造成为“合成生物技术制造领域的龙头企业”。
COMPANY INTRODUTION
Zhejiang Zhenyuan Biotech Co., Ltd. (Zhenyuan Biotech) is a holding subsidiary of Zhejiang Zhenyuan Share Co., Ltd. It is a new state-owned company jointly invested by Zhejiang Zhenyuan Share Co., Ltd. (SZ: 000705) listed on Shenzhen Stock Exchange and its wholly-owned subsidiary Zhejiang Zhenyuan Pharmaceutical Co., Ltd. With a registered capital of 300 million yuan, the company is located in Hangzhou Bay Shangyu Economic and Technological Development Zone, Shaoxing City, Zhejiang Province. There are more than 170kms away from Shanghai and 80kms away from Hangzhou.
Zhenyuan Biotech adheres to the idea of "science and technology is the first productive force", follows the high-quality development concept of "green high end, world leading" and "actively seize the commanding heights of the global industry and comprehensively reshape the core competitiveness of the industry", aims at the general direction of "Healthy China", seizes the opportunity of the rise of global integrated biotechnology applications, and relies on the scientific research cooperation of Chinese Academy of Sciences, domestic famous universities and other research institutions, the biological fermentation method based on synthetic biotechnology is used to produce high-quality and environment-friendly life nutrition.
The products include amino acids, antioxidants, health sugars, functional fatty acids, etc., which are mainly used in medicine, food, health products, feed and other fields.
Adhering to the mission of "continuously meeting people's healthy living needs with green manufacturing", Zhenyuan Biotech is committed to building a leading enterprise in the field of synthetic biotechnology manufacturing".
